The once-weekly insulin icodec, now approved and launched in India for adults living with diabetes, could potentially reduce ...

Introducing continuous glucose monitoring in primary care optimizes diabetes management in underserved populations.

The Center for Integrated and Novel Approaches in Vascular-Metabolic Disease (CINEMA) program is an innovative, patient-centered system of care developed by the University Hospitals Harrington Heart ...

Early Type 1 diabetes experience created durable empathy for loss of control, anticipatory anxiety and treatment fatigue, ...

The 170-acre northeast-side Indianapolis campus is composed of 21 buildings and serves as one of the company’s two global hubs.

A review highlights hearing loss as a hidden complication of type 2 diabetes. It notes that roughly 1 in 4 experience hearing ...

Many adults with diabetes have uncontrolled or previously undiagnosed high blood pressure during their routine visits to ...

Teplizumab is an immunotherapy drug designed to modify the immune system's response. Instead of simply treating symptoms, it works on the underlying cause of Type 1 diabetes. The medicine helps stop ...

Building a system that can recognise risk, guide families, and protect children before Type 1 Diabetes becomes clinical ...

The National Pharmaceutical Pricing Authority (NPPA) has capped the retail prices of 39 commonly used medicines, including ...

Veruschka Pandey's Type 1 Diabetes research examined healthcare challenges and informed recommendations that contributed to ...